Literature DB >> 28489722

Bilateral Herpetic Keratitis After Bilateral Intravitreal Bevacizumab for Exudative Macular Degeneration.

Angeline M Derham1, Eric Chen, Vatinee Y Bunya, Ronan E OʼMalley.   

Abstract

PURPOSE: To report a case of bilateral herpetic epithelial keratitis after bilateral intravitreal bevacizumab injections for the treatment of exudative age-related macular degeneration.
METHODS: A 66-year-old man with diabetes and an extensive history of bilateral anti-vascular endothelial growth factor treatments for exudative age-related macular degeneration received an intravitreal bevacizumab injection in the right eye and triple therapy (bevacizumab, photodynamic therapy, and triamcinolone acetonide) in the left eye. After 4 days, he presented with pain, photophobia, tearing, and decreased vision in both eyes. Slit-lamp examination revealed bilateral dendritic epithelial lesions with terminal bulbs, and he was diagnosed with bilateral herpes simplex epithelial keratitis.
RESULTS: The patient was treated with ganciclovir ophthalmic ointment and oral acyclovir with resolution of signs and symptoms.
CONCLUSIONS: To our knowledge, this is the first documented account of bilateral herpetic epithelial keratitis after bilateral intravitreal bevacizumab injections.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28489722     DOI: 10.1097/ICO.0000000000001233

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  4 in total

Review 1.  Pathogenesis of herpes simplex keratitis: The host cell response and ocular surface sequelae to infection and inflammation.

Authors:  Ann-Marie Lobo; Alex M Agelidis; Deepak Shukla
Journal:  Ocul Surf       Date:  2018-10-11       Impact factor: 5.033

Review 2.  Incidence and Risk Factors of Bilateral Herpetic Keratitis: 2022 Update.

Authors:  Stergios K Chaloulis; Georgios Mousteris; Konstantinos T Tsaousis
Journal:  Trop Med Infect Dis       Date:  2022-06-07

Review 3.  Current Evidence for the Prevention of Endophthalmitis in Anti-VEGF Intravitreal Injections.

Authors:  P Et Lau; K S Jenkins; C J Layton
Journal:  J Ophthalmol       Date:  2018-07-24       Impact factor: 1.909

Review 4.  Ocular manifestations of herpes simplex virus.

Authors:  Gabriel S Valerio; Charles C Lin
Journal:  Curr Opin Ophthalmol       Date:  2019-11       Impact factor: 3.761

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.